Mersana Therapeutics, Inc.
At Close: 4:00 PM
MRSN Stock Price Graph
MRSN Stock Price Today
Mersana Therapeutics, Inc. (MRSN) stock rallied over 2.00% intraday to trade at $1.53 a share on NASDAQ. The stock opened with a loss of -23.27% at $1.22 and touched an intraday high of $1.26, falling -3.77% against the last close of $1.59. The Mersana Therapeutics, Inc. in stock market went to a low of $1.13 during the session.
MRSN Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
MRSN Stock Price History Chart
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also develops XMT-1660, a B7-H4-targeted Dolasynthen ADC candidate; and XMT-2056, an immunosynthen development candidate. It has a strategic research and development partnerships with Merck KGaA and Asana BioSciences, LLC for the development of ADC product candidates utilizing Fleximer. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was incorporated in 2001 and is headquartered in Cambridge, Massachusetts.
Frequently Asked Questions
What is the current Mersana Therapeutics, Inc. (MRSN) stock price?
Mersana Therapeutics, Inc. (NASDAQ: MRSN) stock price is $1.53 in the last trading session. During the trading session, MRSN stock reached the peak price of $1.26 while $1.13 was the lowest point it dropped to. The percentage change in MRSN stock occurred in the recent session was 2.00% while the dollar amount for the price change in MRSN stock was $0.03.
MRSN's industry and sector of operation?
The NASDAQ listed MRSN is part of Biotechnology industry that operates in the broader Healthcare sector. Mersana Therapeutics, Inc. , a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need.
Who are the executives of MRSN?
Ms. Alejandra Veronica Carvajal J.D.
SVice President, Sec. & Chief Legal Officer
Mr. Ashish Mandelia
Vice President, Controller & Principal Accounting Officer
Mr. Brian C. DeSchuytner
Senior Vice President & Chief Financial Officer
Mr. Jason Fredette
Senior Vice President of Investor Relations & Corporation Communications
How MRSN did perform over past 52-week?
MRSN's closing price is 1.63% higher than its 52-week low of $0.801 where as its distance from 52-week high of $9.62 is -0.16%.
How many employees does MRSN have?
Number of MRSN employees currently stands at N/A. MRSN operates from 840 Memorial Drive, Cambridge, MA 02139, US.
Link for MRSN official website?
Official Website of MRSN is: https://www.mersana.com
How do I contact MRSN?
How many shares of MRSN are traded daily?
MRSN stock volume for the day was 638536.00 shares. The average number of MRSN shares traded daily for last 3 months was 2.12 Million.
What is the market cap of MRSN currently?
The market value of MRSN currently stands at $184.49 Million with its latest stock price at $1.53 and N/A of its shares outstanding.